Trakkr
AMBEEPHA

AMBEEPHA share price

Ambee Pharmaceuticals PLC · Pharmaceuticals & Chemicals · Category A

Price

৳702 -⁠0.90 (-0.13%)

Closing prices, 19 Nov 2026 Live prices free with an account

Previous close
৳702.90
Day range
700.10 – 711.50
Volume
584
Turnover
৳4.1L

AMBEEPHA price over the last year

23 Nov 2025 High ৳833 · Low ৳698.20 (closing) 19 Nov 2026

Daily closing prices from DSE, not adjusted for bonus or rights issues.

Reported earnings and NAV

AMBEEPHA earnings per share, NAV per share and operating cash flow per share by period
PeriodEPSNAV / shareNOCFPS
FY27 Q10.3013.83-6.72
FY26 Annual1.0613.5325.82
FY26 Q30.4014.73-22.41
FY26 Q21.3614.33-20.16
FY26 Q10.5013.97-9.28
FY25 Annual2.2113.479.06
FY25 Q30.8513.43-5.69
FY25 Q20.6212.58-19.54

Per-share figures in taka, as published on DSE. Interim EPS is for the period, not annualised.

Latest DSE announcements

  • (Q1 Un-audited): EPS was Tk. 0.30 for July-September 2026 as against Tk. 0.50 for July-September 2025; NOCFPS was Tk. (6.72) for July-September 2026 as against Tk. (9.28) for July-September 2025. NAV per share was Tk. 13.83 as on September 30, 2026 and Tk. 13.53 as on June 30, 2026.

  • The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2026. Date of AGM: 23.12.2026, Time: 11:00 AM, Venue/Mode: Through Online/Digital Platform. Record Date: 02.12.2026. The Company has also reported EPS of Tk. 1.06, NAV per share of Tk. 13.53 and NOCFPS of Tk. 25.82 for the year ended June 30, 2026 as against Tk. 2.21, Tk. 13.47 and Tk. 9.06 respectively for the year ended June 30, 2025.

  • There will be no price limit on the trading of the shares of the Company today (15.11.2026) following its corporate declaration.

  • As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 15, 2026 at 2:30 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.

  • As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2026 at 3:00 PM to consider, among others, annual audited financial statements of the Company for the year ended June 30, 2026.

  • (Q3 Un-audited): EPS was Tk. 0.40 for January-March 2026 as against Tk. 0.85 for January-March 2025; EPS was Tk. 2.26 for July 2025-March 2026 as against Tk. 2.17 for July 2024-March 2025. NOCFPS was Tk. (22.41) for July 2025-March 2026 as against Tk. (5.69) for July 2024-March 2025. NAV per share was Tk. 14.73 as on March 31, 2026 and Tk. 13.47 as on June 30, 2025.

Other Pharmaceuticals & Chemicals shares

Other listings in the Pharmaceuticals & Chemicals sector
TickerPrice%Turnover
ASIATICLABAsiatic Laboratories Limited116.70+1.83%৳16.3Cr
WATACHEMWata Chemicals Limited183.10+8.22%৳11.0Cr
SQURPHARMASquare Pharmaceuticals PLC.209.70-0.29%৳8.4Cr
ACMELABThe ACME Laboratories Limited77.50-3.73%৳3.2Cr
ORIONINFUOrion Infusion Ltd.202.80-0.44%৳2.9Cr
ACMEPLACME Pesticides Limited24.50-0.41%৳2.8Cr

All Pharmaceuticals & Chemicals shares

AMBEEPHA: common questions

What is AMBEEPHA's share price?

AMBEEPHA closed at ৳702 on the Dhaka Stock Exchange (Closing prices, 19 Nov 2026), -⁠0.90 (-0.13%) from the previous close of ৳702.90.

What is AMBEEPHA's 52-week high and low?

Between 23 Nov 2025 and 19 Nov 2026, AMBEEPHA traded as high as ৳847 and as low as ৳681 on DSE.

What is AMBEEPHA's P/E ratio?

At ৳702, AMBEEPHA's P/E ratio is 662.26, on its FY26 earnings per share of ৳1.06.

What dividend did AMBEEPHA declare?

For 2026, Ambee Pharmaceuticals PLC declared a 10% cash dividend. Percentages are of the ৳10 face value.

Which sector is AMBEEPHA in?

Ambee Pharmaceuticals PLC is listed in the Pharmaceuticals & Chemicals sector of the Dhaka Stock Exchange, in category A.

Prices, trades and company figures are from the Dhaka Stock Exchange; prices are at least 15 minutes old. Trakkr is not affiliated with DSE, and nothing here is investment advice.